Article Versions Notes

Kelm M, Kusan S, Surat G, Anger F, Reibetanz J, Germer C-T, Schlegel N, Flemming S. Disease- and Medication-Specific Differences of the Microbial Spectrum in Perianal Fistulizing Crohn’s Disease—Relevant Aspects for Antibiotic Therapy. Biomedicines. 2022; 10(11):2682. https://doi.org/10.3390/biomedicines10112682

Kelm, Matthias, Simon Kusan, Güzin Surat, Friedrich Anger, Joachim Reibetanz, Christoph-Thomas Germer, Nicolas Schlegel, and Sven Flemming. 2022. "Disease- and Medication-Specific Differences of the Microbial Spectrum in Perianal Fistulizing Crohn’s Disease—Relevant Aspects for Antibiotic Therapy" Biomedicines 10, no. 11: 2682. https://doi.org/10.3390/biomedicines10112682

Kelm, M., Kusan, S., Surat, G., Anger, F., Reibetanz, J., Germer, C.-T., Schlegel, N., & Flemming, S. (2022). Disease- and Medication-Specific Differences of the Microbial Spectrum in Perianal Fistulizing Crohn’s Disease—Relevant Aspects for Antibiotic Therapy. Biomedicines, 10(11), 2682. https://doi.org/10.3390/biomedicines10112682